Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma

• Asıl Yazarlar: Junichi Ikeda (Yazar), Chisato Ohe (Yazar), Noritaka Tanaka (Yazar), Takashi Yoshida (Yazar), Ryoichi Saito (Yazar), Naho Atsumi (Yazar), Takashi Kobayashi (Yazar), Hidefumi Kinoshita (Yazar), Koji Tsuta (Yazar), Takeharu Sakamoto (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2023-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Although the introduction of multiple agents targeting immune and oncogenic signaling pathways has substantially changed the treatment strategies for urothelial carcinoma (UC), these drugs still have some limitations, such as adverse effects and limited responses depending on the...